Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines-Reference-Cited by-同舟云学术

Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines

Published:2022-11 Issue: Volume:135 Page:105247
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Trejo-Martin Alejandra^ORCID,Bercu Joel P.,Thresher Andrew,Tennant Rachael E.,Thomas Robert F.,Cross Kevin,Czich Andreas,Waese Kerstin,Nicolette John J.,Murray Joel,Sonders Paul,Kondratiuk Alison,Cheung Jennifer R.,Thomas Dean,Lynch Anthony,Harvey James,Glowienke Susanne,Custer Laura,Escobar Patricia A.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference37 articles.

1. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses;Amberg;Regul. Toxicol. Pharmacol.,2016

2. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test;Ames;Mutat. Res.,1975

3. The mutagenicity of 45 nitrosamines in the Salmonella typhimurium;Andrews;Teratog. Carcinog. Mutagen.,1980

4. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9;Araki;Gan,1984

5. Comparative mutagenicity of N-nitrosamines in a semi-solid and in a liquid incubation system in the presence of rat or human tissue fractions;Bartsch;Mutat. Res.,1976

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine;Regulatory Toxicology and Pharmacology;2024-09

2. Impurities in Active Pharmaceutical Ingredients and Drug Products: A Critical Review;Critical Reviews in Analytical Chemistry;2024-07-26

3. Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential;Environmental and Molecular Mutagenesis;2024-07

4. Metabolic activation of short-chain alkyl N-nitrosamines using Aroclor 1254 or phenobarbital/beta-naphthoflavone-induced rat or hamster S9 – A comparative analysis;Toxicology Reports;2024-06

5. Mind your prevalence!;Journal of Cheminformatics;2024-04-15